Brit Mollenhauer Selected Research

Synucleins

5/2022	Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline.
1/2022	Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
1/2022	Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.
1/2022	Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
1/2022	Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence.
1/2022	The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease.
12/2021	Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.
11/2021	α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease.
7/2021	Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.
1/2021	Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brit Mollenhauer Research Topics

Disease

96	Parkinson Disease (Parkinson's Disease) 10/2022 - 01/2006
41	Dementia (Dementias) 05/2022 - 08/2003
34	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 11/2004
33	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2003
19	Cognitive Dysfunction 05/2022 - 01/2006
15	Disease Progression 05/2022 - 01/2005
8	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2022 - 08/2003
8	Synucleinopathies 01/2022 - 03/2011
8	Multiple System Atrophy 01/2022 - 03/2011
6	Tremor (Tremors) 01/2022 - 12/2011
6	Parkinsonian Disorders (Parkinsonism) 03/2021 - 10/2010
5	Sporadic Creutzfeldt-Jakob Disease 01/2022 - 10/2008
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2021 - 03/2011
5	Movement Disorders (Movement Disorder) 01/2021 - 07/2009
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022 - 06/2017
4	Nervous System Diseases (Neurological Disorders) 01/2019 - 03/2011
4	Frontotemporal Dementia (Semantic Dementia) 10/2015 - 10/2008
3	Inflammation (Inflammations) 01/2022 - 08/2017
3	REM Sleep Behavior Disorder 01/2021 - 07/2017
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2013 - 01/2011
2	Dystonia (Limb Dystonia) 01/2022 - 01/2021
2	Fatal Familial Insomnia 01/2022 - 01/2021
2	Corticobasal Degeneration 12/2021 - 10/2014
2	Hypokinesia (Bradykinesia) 01/2021 - 12/2018
2	Lewy Body Disease (Lewy Body Dementia) 01/2016 - 10/2015
2	Brain Diseases (Brain Disorder) 01/2015 - 03/2011
2	Primary Progressive Aphasia 10/2014 - 01/2011
2	Atrophy 04/2014 - 11/2005
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2008 - 10/2007
1	Neuroinflammatory Diseases 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021
1	Dyskinesias (Dyskinesia) 05/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2020
1	Prodromal Symptoms 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Chronic Progressive Multiple Sclerosis 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Alcoholism (Alcohol Abuse) 01/2019
1	Autoimmune Diseases of the Nervous System 01/2019

Drug/Important Bio-Agent (IBA)

89	Biomarkers (Surrogate Marker)IBA 05/2022 - 11/2004
50	SynucleinsIBA 05/2022 - 06/2010
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
13	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2011
13	alpha-SynucleinIBA 01/2022 - 08/2008
10	Biological ProductsIBA 10/2022 - 04/2012
9	tau Proteins (tau Protein)IBA 12/2021 - 01/2005
8	Pharmaceutical PreparationsIBA 02/2022 - 01/2013
8	Amyloid beta-PeptidesIBA 01/2016 - 08/2003
6	EnzymesIBA 03/2021 - 01/2006
6	Peptides (Polypeptides)IBA 07/2012 - 08/2003
5	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2012
3	AutoantibodiesIBA 01/2022 - 10/2014
3	Levodopa (L Dopa)FDA LinkGeneric 05/2021 - 09/2017
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 12/2018
3	Leucine (L-Leucine)FDA Link 01/2021 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
3	Apolipoproteins E (ApoE)IBA 12/2020 - 04/2014
3	AntibodiesIBA 01/2020 - 10/2014
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020 - 04/2013
3	Fatty Acid Binding Protein 3IBA 07/2017 - 11/2004
3	ApolipoproteinsIBA 01/2016 - 01/2006
3	ImmunosorbentsIBA 09/2015 - 01/2007
2	Codon (Codons)IBA 01/2022 - 01/2021
2	Prion ProteinsIBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2010
2	Uric Acid (Urate)IBA 01/2020 - 01/2019
2	Immunoglobulin A (IgA)IBA 01/2019 - 10/2014
2	Immunoglobulin M (IgM)IBA 01/2019 - 10/2014
2	Immunoglobulin G (IgG)IBA 01/2019 - 10/2014
2	N-Methylaspartate (NMDA)IBA 01/2019 - 10/2014
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2015 - 04/2014
2	EpitopesIBA 10/2014 - 11/2012
2	Cholinergic Agents (Cholinergics)IBA 04/2014 - 10/2010
2	Protein Isoforms (Isoforms)IBA 11/2012 - 01/2006
2	14-3-3 Proteins (14-3-3 Protein)IBA 10/2008 - 01/2007
1	Lipoproteins (Lipoprotein)IBA 02/2022
1	ORALIT (ORS)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	PrionsIBA 01/2022
1	Histone-Lysine N-MethyltransferaseIBA 01/2022
1	BenzodiazepinesIBA 05/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2020
1	SulfurIBA 11/2019
1	Piwi-Interacting RNAIBA 10/2019
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2019
1	HDL LipoproteinsIBA 01/2019
1	HDL CholesterolIBA 01/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2019
1	Therapeutic UsesIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2019

Therapy/Procedure

5	Therapeutics 07/2021 - 10/2016
1	Deep Brain Stimulation 01/2022